Access cutting-edge cirrhosis treatment through this clinical trial at a research site in Peoria. Study-provided care at no cost to qualified participants.
Access cirrhosis specialists in Peoria at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cirrhosis treatment provided free
The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants with metabolic dysfunction associated steatohepatitis (MASH) and compensated cirrhosis consistent with stage F4 fibrosis.
Sponsor: Boston Pharmaceuticals
Check if you qualify for this cirrhosis clinical trial in Peoria, AZ
If you're searching for cirrhosis treatment options in Peoria, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Peoria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cirrhosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.